Axel Nielsen, chief operating officer of Decode Genetics, has resigned from the company, effective Jan. 1. The firm disclosed the resignation in a recent US Securities and Exchange Commission filing, but it did not say whether it intends to search for a replacement.
David Macdonald has taken on the job of interim CEO at GeneLink BioSciences. He takes over the role from Monte Taylor, who has been serving as CEO of both GeneLink and its Genewize subsidiary, but who will now focus on growing the GeneWize business.
Macdonald was president and COO at Nichols Institute Diagnostics, and he later became vice president at Quest Diagnostics. He also was CEO and director at AltheaDx, CEO and president at Nanomix, and VP of global and business development at Nanogen.
Sequenom has appointed Kenneth Buechler and David Pendarvis to its board of directors. Buechler previously was president, chief scientific officer, and co-founder of Biosite. Pendarvis is senior VP of organizational development, global general counsel, and secretary of ResMed.
Robert Langer has been named to Millipore's board of directors, where he will take the place of exiting director Daniel Bellus. Langer is the David H. Koch Institute Professor at the Massachusetts Institute of Technology. He also serves on the board of MIT's McGovern Institute and Whitehead Institute.